Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-14

Clinical Trial Update: Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug [Phase 4]

View source ↗

Summary

Phase 4 trial evaluated whether continuing zonisamide as adjunctive therapy is more effective or safer than replacing the last added antiepileptic drug with zon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonisamide (zonisamide)

Snippet

Sponsor: Eisai Inc. | Conditions: Partial Seizures | Phase 4 | Status: COMPLETED